,dataset_name,cell_type,cell_type_ontology_id,donor_id,sex,race,development_stage,count,percentage
0,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",T cell,CL:0000084,JP_RIK_H049,female,Japanese,33-year-old human stage,16,0.7111111111111111
1,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",platelet,CL:0000233,JP_RIK_H049,female,Japanese,33-year-old human stage,9,0.4
2,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",B cell,CL:0000236,JP_RIK_H049,female,Japanese,33-year-old human stage,7,0.3111111111111111
3,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",monocyte,CL:0000576,JP_RIK_H049,female,Japanese,33-year-old human stage,30,1.3333333333333335
4,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",natural killer cell,CL:0000623,JP_RIK_H049,female,Japanese,33-year-old human stage,5,0.2222222222222222
5,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta T cell",CL:0000624,JP_RIK_H049,female,Japanese,33-year-old human stage,41,1.8222222222222224
6,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta T cell",CL:0000625,JP_RIK_H049,female,Japanese,33-year-old human stage,17,0.7555555555555555
7,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",plasmacytoid dendritic cell,CL:0000784,JP_RIK_H049,female,Japanese,33-year-old human stage,2,0.08888888888888889
8,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mature B cell,CL:0000785,JP_RIK_H049,female,Japanese,33-year-old human stage,17,0.7555555555555555
9,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",plasma cell,CL:0000786,JP_RIK_H049,female,Japanese,33-year-old human stage,3,0.13333333333333333
10,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",memory B cell,CL:0000787,JP_RIK_H049,female,Japanese,33-year-old human stage,66,2.933333333333333
11,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",naive B cell,CL:0000788,JP_RIK_H049,female,Japanese,33-year-old human stage,79,3.5111111111111115
12,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta cytotoxic T cell",CL:0000794,JP_RIK_H049,female,Japanese,33-year-old human stage,23,1.0222222222222224
13,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",gamma-delta T cell,CL:0000798,JP_RIK_H049,female,Japanese,33-year-old human stage,14,0.6222222222222222
14,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",regulatory T cell,CL:0000815,JP_RIK_H049,female,Japanese,33-year-old human stage,41,1.8222222222222224
15,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD4-positive, alpha-beta T cell",CL:0000895,JP_RIK_H049,female,Japanese,33-year-old human stage,486,21.6
16,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD8-positive, alpha-beta T cell",CL:0000900,JP_RIK_H049,female,Japanese,33-year-old human stage,295,13.111111111111112
17,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","central memory CD4-positive, alpha-beta T cell",CL:0000904,JP_RIK_H049,female,Japanese,33-year-old human stage,148,6.577777777777778
18,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","effector memory CD4-positive, alpha-beta T cell",CL:0000905,JP_RIK_H049,female,Japanese,33-year-old human stage,25,1.1111111111111112
19,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta memory T cell",CL:0000909,JP_RIK_H049,female,Japanese,33-year-old human stage,39,1.7333333333333332
20,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta cytotoxic T cell",CL:0000934,JP_RIK_H049,female,Japanese,33-year-old human stage,2,0.08888888888888889
21,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-negative, CD56-bright natural killer cell, human",CL:0000938,JP_RIK_H049,female,Japanese,33-year-old human stage,13,0.5777777777777777
22,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-positive, CD56-dim natural killer cell, human",CL:0000939,JP_RIK_H049,female,Japanese,33-year-old human stage,348,15.466666666666667
23,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mucosal invariant T cell,CL:0000940,JP_RIK_H049,female,Japanese,33-year-old human stage,54,2.4
24,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD14-positive monocyte,CL:0001054,JP_RIK_H049,female,Japanese,33-year-old human stage,359,15.955555555555556
25,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD14-low, CD16-positive monocyte",CL:0002396,JP_RIK_H049,female,Japanese,33-year-old human stage,90,4.0
26,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD1c-positive myeloid dendritic cell,CL:0002399,JP_RIK_H049,female,Japanese,33-year-old human stage,21,0.9333333333333335
